newsfilter
← Latest News
Business Wire·

Appili Therapeutics Reports Fiscal Year 2023 Financial and Operational Results

Executed US$7.3M initial contract with U.S. Air Force Academy for ATI-1701 Upcoming PDUFA date of September 23, 2023 for ATI-1501 Appili Therapeutics Inc. (TSX:APLI, OTCQB:APLIF) (the "Company" or "Appili"), a